Latest Strategy News

Antilles Gold Limited reports significant progress on its Cuban joint venture projects, including updated resource estimates and feasibility studies, while managing a constrained cash position heading into 2025.

Revolver Resources reports encouraging leach test results at its Dianne Copper Mine, moving closer to production in H2 2025, while securing new funding through a royalty agreement to support development and exploration.

Pursuit Minerals has reported a remarkable 339% increase in lithium resources at its Rio Grande Sur project in Argentina, alongside plans to commence lithium carbonate production by Q1 2025. The company is also actively pursuing acquisitions and reviewing its gold assets amid tight cost controls.

Ovanti Limited has made significant strides in its plan to enter the US Buy Now Pay Later market, delivering a comprehensive strategic report and strengthening its executive team to support expansion.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Magnis Energy Technologies reports ongoing progress on its Nachu Graphite Project while grappling with Imperium3’s bankruptcy and a prolonged ASX trading suspension.

Purifloh Limited has made significant progress in its PFAS destruction technology, securing a $100,000 BRII feasibility grant while navigating challenges to resume trading on the ASX.

Adelong Gold Limited's December 2024 quarterly report reveals promising new drill targets near the Adelong Mill and a binding farm-in agreement with Great Divide Mining to accelerate gold production.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Jindalee Lithium Limited reported a $935,000 net cash outflow for the December 2024 quarter, maintaining a cautious but confident stance on securing future funding to support ongoing exploration activities.

Paterson Resources Limited reports significant progress at its Grace Gold-Copper Project, including promising drilling results and key steps toward resource upgrading and mining lease application.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.